Levodopa-carbidopa intestinal gel for managing severe refractory tremors of idiopathic Parkinson’s disease: Case Series
Objective: To report our experience with the use of levodopa-carbidopa intestinal gel (LCIG) infusion therapy for the treatment of four patients with idiopathic Parkinson’s disease…Early versus late levodopa administration in Parkinson’s disease: Comparative study
Objective: To evaluate levodopa-sparing strategy in terms of motor decline and complications. Background: Levodopa remains the gold standard for treatment of Parkinson’s disease(PD), as it…The Quebec Parkinson Network (QPN): Interdisciplinary Collaboration in Parkinson’s Disease and Related Disorders Research.
Objective: By creating a participant registry, gathering information on participants, and ensuring appropriate data exchange with research groups, the QPN's primary goal is to increase…PD-PROP reporting in participants own words shows high burden of cognitive symptoms in early Parkinson Disease (PD)
Objective: Describe the relative frequency of bothersome cognitive symptoms reported verbatim by people with PD in the Fox Insight online study. Background: Cognitive decline is…Loneliness, Self-Efficacy, and Resilience: Neglected Modifiable Contributors to Parkinson’s Disease Symptom Severity and Quality of Life
Objective: To evaluate the degree to which modifiable psychosocial (PS) variables including loneliness, self-efficacy (SE) and resilience explain the variance observed in Parkinson’s disease (PD)…GBA p.K198E mutation causing Parkinson Disease in Colombian population: the first clinical description
Objective: Describe the main clinical features of three subjects with inherited Parkinson's disease (PD) due to glucocerebrosidase (GBA) p.K198E substitution. Background: Recessive mutation of the…Movement-related modulation of beta/high frequency oscillations and low-beta pallido-cortical coherence in Parkinson’s disease.
Objective: To characterize changes in synchronized oscillatory activity and coherence between the globus pallidus (GPi) and primary motor cortex (M1) of Parkinson’s disease (PD) patients…Neurologic dysfunction assessment in Parkinson’s disease based on fundus photographs using deep learning
Objective: To develop an algorithm that can predict Hoehn and Yahr (H–Y) and Unified Parkinson's Disease Rating Scale part III (UPDRS-III) scores using fundus photography among…Efficacy and safety of foslevodopa/foscarbidopa continuous subcutaneous infusion administered as monotherapy in patients with Parkinson’s disease
Objective: To report the efficacy and safety profiles of patients on sustained foslevodopa/foscarbidopa (LDP/CDP) continuous subcutaneous infusion (CSCI) mono- or polytherapy from three phase 3…Unsupervised physical capacity testing at home: a systematic review
Objective: Systematically review home-based physical capacity tests and their clinimetric properties in different patient populations with a chronic disease. Background: Physical capacity is a predictor…
- « Previous Page
- 1
- …
- 223
- 224
- 225
- 226
- 227
- …
- 436
- Next Page »